Quantcast

Latest pharmaceutical industry Stories

2014-06-18 08:29:23

BAUDETTE, Minn., June 18, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has signed an exclusive license and supply agreement with Dexcel Pharma Technologies Ltd. ("Dexcel") for an ANDA drug product. Dexcel submitted the ANDA application in December 2011. Dexcel will be responsible for obtaining FDA approval and manufacturing the product, and ANI Pharmaceuticals will be responsible for marketing and distribution in the U.S. The product generates combined brand and...

2014-06-18 08:28:27

PRINCETON, N.J., June 18, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that Al Altomari, the Company's Chief Executive Officer and President, will participate at the Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day on June 26, 2014 in Boston, MA. About Agile Agile Therapeutics is a women's...

2014-06-18 08:24:53

MORRISTOWN, N.J., June 18, 2014 /PRNewswire/ -- Atlantic Health System has launched a new website that provides information about open and enrolling clinical trials and research studies across Atlantic Health System medical centers. The tablet and smartphone-friendly website, atlantichealth.org/research, features a search tool that allows visitors to easily find trials based on disease area, keywords, and the name of physicians conducting trials. Atlantic Health System, which...

2014-06-17 16:26:03

-- No additional clinical trials requested by the FDA RIDGEFIELD, Conn. and INDIANAPOLIS, June 17, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced the resubmission of a New Drug Application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment of adults with type 2 diabetes (T2D) to the U.S. Food and Drug Administration (FDA). The Class 1 resubmission...

2014-06-17 16:24:48

LONDON, June 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Celldex Therapeutics, Inc. - Product Pipeline Review - 2014http://www.reportbuyer.com/pharma_healthcare/treatments/celldex_therapeutics_inc_product_pipeline_review_2013.htmlCelldex Therapeutics, Inc. - Product Pipeline Review - 2014 SummaryGlobal Markets Direct's, 'Celldex Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Celldex Therapeutics, Inc.'s...

2014-06-17 12:29:50

MANCHESTER, England and CAMBRIDGE, Massachusetts, June 17, 2014 /PRNewswire/ -- Retrogenix [http://www.retrogenix.com ] today announces that it has opened its first office in the United States - the fastest growing regional market for the UK-based biotech which provides drug target screening services to global pharmaceutical clients. Retrogenix's location in Kendall Square, Cambridge, MA, places the company close to its client base and within an internationally-recognised hub...

2014-06-17 12:29:08

Selected academic researchers to receive access to AstraZeneca's compound library to aid in the discovery of new medicines BALTIMORE, June 17, 2014 /PRNewswire-USNewswire/ -- The Academic Drug Discovery Consortium (ADDC) announced today a collaboration between ADDC and AstraZeneca aimed at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application. More specifically, the goal of this...

2014-06-17 12:28:55

DALLAS, June 17, 2014 /PRNewswire/ -- According to new Market Research Report "Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018" published by MarketsandMarkets, The global Molecular Diagnostics Market will reach $7,956.9 Million by 2018, growing at a CAGR of 9.7% during the...

2014-06-17 12:28:44

AACHEN, Germany, June 17, 2014 /PRNewswire/ -- Gruenenthal Group announces its newsearch fields for licensing and acquisition in R&D and for marketed assets at the 2014 BIO International Convention, the world's largest partnering event for the biotechnology industry. The family owned, mid-sized research driven pharmaceutical company headquartered in Aachen, Germany, will be sharing with the biotech community its new approach to M&A and licensing. Gruenenthal, which...

2014-06-17 12:28:31

Given the Size and Growth of Colombia's Generic Sector There is Potential for Both Domestic and International Companies, According to Findings from Decision Resources Group BURLINGTON, Mass., June 17, 2014 /PRNewswire/ -- Decision Resources Group finds that Colombia has an attractive pharmaceutical market that should appeal to multinational companies looking for emerging growth opportunities. Colombia is experiencing increasing demand for pharmaceutical products as a result of the country's...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related